Literature DB >> 26525165

Economic evaluation of a psychological intervention for high distress cancer patients and carers: costs and quality-adjusted life years.

Mary Lou Chatterton1, Suzanne Chambers2,3,4, Stefano Occhipinti2, Afaf Girgis5, Jeffrey Dunn2,3,6,7, Rob Carter1, Sophy Shih1, Cathrine Mihalopoulos1.   

Abstract

OBJECTIVE: This study compared the cost-effectiveness of a psychologist-led, individualised cognitive behavioural intervention (PI) to a nurse-led, minimal contact self-management condition for highly distressed cancer patients and carers.
METHODS: This was an economic evaluation conducted alongside a randomised trial of highly distressed adult cancer patients and carers calling cancer helplines. Services used by participants were measured using a resource use questionnaire, and quality-adjusted life years were measured using the assessment of quality of life - eight-dimension - instrument collected through a computer-assisted telephone interview. The base case analysis stratified participants based on the baseline score on the Brief Symptom Inventory. Incremental cost-effectiveness ratio confidence intervals were calculated with a nonparametric bootstrap to reflect sampling uncertainty. The results were subjected to sensitivity analysis by varying unit costs for resource use and the method for handling missing data.
RESULTS: No significant differences were found in overall total costs or quality-adjusted life years (QALYs) between intervention groups. Bootstrapped data suggest the PI had a higher probability of lower cost and greater QALYs for both carers and patients with high distress at baseline. For patients with low levels of distress at baseline, the PI had a higher probability of greater QALYs but at additional cost. Sensitivity analysis showed the results were robust.
CONCLUSIONS: The PI may be cost-effective compared with the nurse-led, minimal contact self-management condition for highly distressed cancer patients and carers. More intensive psychological intervention for patients with greater levels of distress appears warranted.
Copyright © 2015 John Wiley & Sons, Ltd. Copyright © 2015 John Wiley & Sons, Ltd. Copyright © 2015 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Year:  2015        PMID: 26525165     DOI: 10.1002/pon.4020

Source DB:  PubMed          Journal:  Psychooncology        ISSN: 1057-9249            Impact factor:   3.894


  6 in total

Review 1.  Cost-Utility Analyses of Interventions for Informal Carers: A Systematic and Critical Review.

Authors:  Wilfried Guets; Hareth Al-Janabi; Lionel Perrier
Journal:  Pharmacoeconomics       Date:  2020-04       Impact factor: 4.981

2.  A systematic review of economic analyses of psychological interventions and therapies in health-related settings.

Authors:  Leeanne Nicklas; Mairi Albiston; Martin Dunbar; Alan Gillies; Jennifer Hislop; Helen Moffat; Judy Thomson
Journal:  BMC Health Serv Res       Date:  2022-09-07       Impact factor: 2.908

Review 3.  A Review on Cost-Effectiveness and Cost-Utility of Psychosocial Care in Cancer Patients.

Authors:  Femke Jansen; Valesca van Zwieten; Veerle M H Coupé; C René Leemans; Irma M Verdonck-de Leeuw
Journal:  Asia Pac J Oncol Nurs       Date:  2016 Apr-Jun

4.  Costs from a healthcare and societal perspective among cancer patients after total laryngectomy: are they related to patient activation?

Authors:  Femke Jansen; Veerle M H Coupé; Simone E J Eerenstein; C René Leemans; Irma M Verdonck-de Leeuw
Journal:  Support Care Cancer       Date:  2017-11-03       Impact factor: 3.603

5.  The Moo'D Study: protocol for a randomised controlled trial of A2 beta-casein only versus conventional dairy products in women with low mood.

Authors:  Meghan Hockey; Hajara Aslam; Michael Berk; Julie A Pasco; Anu Ruusunen; Mohammadreza Mohebbi; Helen Macpherson; Mary Lou Chatterton; Wolfgang Marx; Adrienne O'Neil; Tetyana Rocks; Amelia J McGuinness; Lauren M Young; Felice N Jacka
Journal:  Trials       Date:  2021-12-11       Impact factor: 2.279

6.  Target-D: a stratified individually randomized controlled trial of the diamond clinical prediction tool to triage and target treatment for depressive symptoms in general practice: study protocol for a randomized controlled trial.

Authors:  Jane Gunn; Caroline Wachtler; Susan Fletcher; Sandra Davidson; Cathrine Mihalopoulos; Victoria Palmer; Kelsey Hegarty; Amy Coe; Elizabeth Murray; Christopher Dowrick; Gavin Andrews; Patty Chondros
Journal:  Trials       Date:  2017-07-20       Impact factor: 2.279

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.